scholarly journals Evaluation of a Perinatal Human Papillomavirus Program

2018 ◽  
Author(s):  
Melissa Maher
Keyword(s):  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
Sexual Debut ◽  
The United States ◽  
Hpv Infection ◽  
Pilot Program ◽  
Postpartum Visit ◽  
Transmitted Infection ◽  
Advanced Nursing Practice ◽  
Vaccination Rates

Human papillomavirus (HPV) is recognized as the most prevalent sexually transmitted infection in the United States. Prevention of HPV infection is possible with the efficacy of HPV vaccine noted to be nearly 100% when introduced prior to sexual debut. In addition, vaccination post-sexual initiation could have a significant impact on reducing HPV infection and HPV-associated cancers in women. Much focus has been placed on vaccinating adolescents against HPV. However, strategies to increase vaccination rates among females ages 18-26, who remain eligible for vaccination, must be examined. A program evaluation was undertaken to assess the effectiveness of a newly developed pilot program for women ages 19-26 that incorporates assessment of vaccine eligibility during the prenatal period to increase uptake and completion of HPV vaccine postpartum. Data collected from the perinatal vaccination pilot program was performed retrospectively. Through a chart review, postpartum patients age 19-26 were identified and specific areas of focus were examined: whether an HPV dose was administered to vaccine eligible individuals during the inpatient period; whether an additional dose was administered at an ambulatory postpartum visit; and whether a subsequent dose was given at an ambulatory visit if warranted. Data analysis was conducted. Frequencies and percentages in relation to numbers of patients and HPV doses were calculated. Finally, implications for advanced nursing practice were discussed.

Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women

2020 ◽  
Vol 31 (10) ◽  
pp. 976-981
Author(s):  
Robert J Zeglin ◽  
Juliet L Fetteroll
Keyword(s):  
Human Papillomavirus ◽  
Hpv Vaccine ◽  
Sexual Debut ◽  
Secondary Data ◽  
Hpv Infection ◽  
Nutrition Examination Survey ◽  
Human Papillomavirus Vaccine ◽  
Vaccination Rates ◽  
Health And Nutrition ◽  
Papillomavirus Vaccine

Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women’s health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls. Delaying vaccination until after sexual debut increases a woman’s chance of HPV infection, but there has been no quantification of this risk in the literature. The present study sought to address this gap via secondary data analysis with 173 female participants from the 2015–2016 National Health and Nutrition Examination Survey dataset. Results indicate that women in the sample who received the HPV vaccine after their sexual debut were 2.63 times more likely than women who receive the vaccine before their sexual debut to report an HPV diagnosis. These results have clear public and sexual health implications.

scholarly journals 1641. A Comparison of Human Papilloma Virus Infection Prevalence Trends Pre- and Post-HPV Vaccine Implementation

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S599-S599
Author(s):  
Patrick Ovie. Fueta ◽  
Onyema Greg Chido-Amajuoyi
Keyword(s):  
United States ◽  
Human Papilloma Virus ◽  
Hpv Vaccine ◽  
Human Papilloma Virus Infection ◽  
The United States ◽  
Hpv Infection ◽  
Infection Prevalence ◽  
Transmitted Infection ◽  
Papilloma Virus ◽  
The Impact

Abstract Background Human papilloma virus (HPV) is the most common sexually transmitted infection in the United States, with an annual incidence rate of approximately 14 million people. The HPV vaccine has been demonstrated to be highly effective in the prevention of HPV infection and HPV-associated diseases. This study aims to evaluate the impact of HPV vaccine on the prevalence of HPV infection in the United States and evaluate the trends of disease prevalence pre- and post-HPV vaccine implementation. Methods We conducted a secondary data analysis of the National Health and Education Survey (NHANES) for trends in HPV infection from 2003 to 2016. The analysis was grouped into a pre-HPV vaccine implementation (2003–2006) cohort including 4064 females, aged 18–59 years; and a post-HPV vaccine implementation (2007–2016) cohort which included 10718 females, aged 18–59 years. Further analysis of HPV infection prevalence, pre- and post-HPV vaccine implementation, stratified by sociodemographic characteristics were conducted. Results The prevalence of HPV infection prior to HPV vaccine implementation was 43.98% (95 CI 42.71%–46.58%) compared with 40.55% (95 C.I 40.55%–40.56%) in the post-HPV vaccine implementation era. Among females with HPV infections in the post-HPV vaccine implementation cohort 82.6 (95% CI 80.41%–83.42%) were unvaccinated. In both cohorts, black females had a significantly higher prevalence of HPV with a prevalence rate of 18.56% (95% CI 18.23%–20.56%) in the pre-HPV vaccine implementation cohort, and 15.61% (95% CI 14.82 – 19.4%) in the post-HPV vaccine implementation cohort. Females with less than high school education had a higher prevalence of HPV in the pre and post- HPV vaccine implementation cohorts with prevalence rates of 25.77% (95% CI 23.44%–28.72%) and 24.96% (95% CI 23.41%–25.67%), respectively. Conclusion The results suggest that HPV infection prevalence has declined since the implementation of HPV vaccine to US national immunization program. Our findings highlight disparities in HPV infection prevalence by race and educational status, and these patterns are in keeping with HPV-associated disease such as warts and HPV-associated cancers. Disclosures All authors: No reported disclosures.

Review of Evidence and Recommendation for Human Papillomavirus (HPV) Vaccination of Canadian Males Over the Age of 26 Years

2020 ◽  
Vol 24 (3) ◽  
pp. 285-291 ◽  
Author(s):  
Alex Derstenfeld ◽  
Kyle Cullingham ◽  
Zhuo Cai Ran ◽  
Ivan V. Litvinov
Keyword(s):  
Human Papillomavirus ◽  
Sexually Transmitted Infection ◽  
Hpv Vaccine ◽  
Hpv Vaccination ◽  
Older Men ◽  
Hpv Infection ◽  
Transmitted Infection ◽  
Vaccination Programs ◽  
Sexually Transmitted ◽  
Control And Prevention

Human papillomavirus (HPV) remains the most common sexually transmitted infection with a lifetime incidence of over 75%. Based on US data from the Centers for Disease Control and Prevention (CDC), 64% of invasive HPV-associated cancers are attributable to HPV 16 or 18 (65% for females; 63% males) and may be prevented by vaccination with either the quadrivalent or nonavalent HPV vaccine. Public HPV vaccination programs are now the norm for women aged 9-45 years and men aged 9-26 years in Canada. Yet, only recently have guidelines begun to consider vaccination of men older than 26 years of age. There now exist compelling reasons to recommend vaccination against HPV amongst males >26 years of age. Recognizing that the risks posed by HPV infection persist beyond 26 years of age, that the vaccination of men aged 26-45 years with HPV vaccine confers immunogenicity at levels demonstrably efficacious against HPV-related diseases, and that the Food and Drug Administration recently expanded the HPV vaccination to include older men, it is argued that HPV vaccination in men older than 26 years of age should be routinely recommended.

scholarly journals Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study

JMIR Nursing ◽  
10.2196/19503 ◽  
2020 ◽  
Vol 3 (1) ◽  
pp. e19503
Author(s):  
Anne M Teitelman ◽  
Emily F Gregory ◽  
Joshua Jayasinghe ◽  
Zara Wermers ◽  
Ja H Koo ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Technology Acceptance ◽  
Hpv Vaccine ◽  
Hpv Vaccination ◽  
Behavioral Model ◽  
The United States ◽  
Mobile App ◽  
Vaccine Uptake ◽  
Human Papillomavirus Vaccine ◽  
Vaccination Rates

Background More than 90% of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine, yet vaccine use in the United States falls short of public health goals. Objective The purpose of this study was to describe the development, acceptability, and intention to use the mobile app Vaccipack, which was designed to promote uptake and completion of the adolescent HPV vaccine series. Methods Development of the mobile health (mHealth) content was based on the integrated behavioral model (IBM). The technology acceptance model (TAM) was used to guide the app usability evaluation. App design utilized an iterative process involving providers and potential users who were parents and adolescents. App features include a vaccine-tracking function, a discussion forum, and stories with embedded messages to promote intention to vaccinate. Parents and adolescents completed surveys before and after introducing the app in a pediatric primary care setting with low HPV vaccination rates. Results Surveys were completed by 54 participants (20 adolescents aged 11 to 14 years and 34 parents). Notably, 75% (15/20) of adolescents and 88% (30/34) of parents intended to use the app in the next 2 weeks. Acceptability of the app was high among both groups: 88% (30/34) of parents and 75% (15/20) of adolescents indicated that Vaccipack was easy to use, and 82% (28/34) of parents and 85% (17/20) of adolescents perceived the app to be beneficial. Higher levels of app acceptability were found among parents with strong intentions to use the app (P=.09; 95% CI –2.15 to 0.15). Conclusions mHealth technology, such as Vaccipack, may be an acceptable and nimble platform for providing information to parents and adolescents and advancing the uptake of important vaccines.

scholarly journals A Child Rights and Social Justice Framework for Analyzing Public Policy

2015 ◽  
Vol 2 (1) ◽  
Author(s):  
Rita Nathawad ◽  
David L Wood ◽  
Jeffrey L Goldhagen
Keyword(s):  
Social Justice ◽  
Hpv Vaccine ◽  
Well Being ◽  
The United States ◽  
Hpv Infection ◽  
Vaccine Uptake ◽  
Medical Decision ◽  
Transmitted Infection ◽  
Child Rights ◽  
Effective Measure

Human papilloma virus (HPV) is the most common sexually transmitted infection (STI) in the United States (U.S.).  Despite data that supports HPV vaccine as an effective measure to prevent anogenital cancers, vaccine uptake rates in the U.S. have stagnated over the past few years and only one third of adolescents are fully immunized.  Adolescents are able to independently access STI diagnosis and treatment in all fifty states and the District of Columbia.  However, only California allows adolescents to obtain HPV vaccine without parental consent.  This creates a paradox where youth are able to independently receive treatment for HPV infection but not for its prevention.  Current approaches to HPV vaccine education and delivery have not been successful at improving immunization rates.  In this paper we propose the implementation of a child rights, social justice, and health equity-based approach to frame HPV vaccine policy.  Such an approach to vaccine policy will promote children’s participation in medical decision-making.  We postulate that by empowering children to be involved in issues pertaining to their health and well-being, they will be more likely to discuss HPV with their peers or families, and potentially be able to make informed independent decisions related to HPV vaccine.

scholarly journals Digital Gaming Interventions– Utilizing Theories and Evaluation to Increase HPV Vaccination among Young Males (Preprint)

2020 ◽  
Author(s):  
Gabrielle Darville ◽  
Jade Burns ◽  
Tanaka Chavanduka ◽  
Charkarra Anderson - Lewis
Keyword(s):  
Hpv Vaccine ◽  
Game Design ◽  
Hpv Vaccination ◽  
Intervention Mapping ◽  
Health Belief ◽  
Theoretical Models ◽  
The United States ◽  
Vaccine Uptake ◽  
Transmitted Infection ◽  
Vaccination Rates

UNSTRUCTURED The Human Papillomavirus (HPV) is the most common sexually transmitted infection in the US. HPV attributes to most cancers including anal, oral, cervical and penile. Despite infection rates in the United States recommendations and communication campaigns have traditionally focused on females. Because of this, males lack knowledge of reasons for vaccination, the benefits of being vaccinated and their risks overall. Gaming as a health education strategy can be beneficial for this key demographic because of the popularity and gaming mechanism that can promote behavior change. Objective: This study sought to explore the relationship between gamification and HPV vaccine uptake. Materials and Methods: In total twenty two (n=22) interviews were conducted with experts in the fields of cancer prevention, sexual and reproductive health, public health, game design, technology and health communication on how a game should be developed to increase HPV vaccination rates among males. Results: Overwhelmingly theoretical models such as the health belief model (HBM) were identified with key constructs such as self-efficacy and risk perception. Experts also suggested using intervention mapping and logic models as planning tools for health promotion interventions utilizing a digital game as a medium. Lastly, in game and out of game measures were discussed as assessments for quality and impact by our expert panel. Conclusion: This study shows that interventions should focus on whether greater utilization of serious games and the incorporation of theory and standardized methods can impact the need of young men to vaccinate and complete the series of the HPV vaccine.

scholarly journals Knowledge of Human Papillomavirus and Uptake of its Vaccine among Female Undergraduate Students of Ambrose Alli University, Ekpoma, Nigeria

2021 ◽  
Vol 33 (1) ◽  
pp. 64-75
Author(s):  
A.R. Isara ◽  
N. Osayi
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Undergraduate Students ◽  
Hpv Vaccine ◽  
Sexual Debut ◽  
Statistical Significance ◽  
Hpv Infection ◽  
Vaccine Uptake ◽  
P Value ◽  
Female Undergraduate

Background: Human Papillomavirus (HPV) is a prerequisite for the development of cervical cancer which is the fourth most common cancer affecting women worldwide. The use of HPV vaccine has been found to be responsible for significant decline in the prevalence of HPV infection and consequently, of cervical cancer. This study assessed the knowledge of HPV and the uptake of HPV vaccine among female undergraduate students of Ambrose Alli University, Ekpoma, Nigeria.Methods: This institution-based cross-sectional study was carried out among 229 students selected using multi-staged sampling technique. A structured, pretested, self-administered questionnaire was used to collect data. IBM SPSS version 21.0 was used for data analysis. Statistical significance was set at p-value less than 0.05.Results: Only 12 (5.2%) students were knowledgeable about HPV and 39 (17.0%) were aware of the existence of HPV vaccines. The participants’ age (p = 0.031) and level of study (p = 0.026) were significantly associated with knowledge of HPV. Only 1 (0.44%) student had received the vaccine. Eight (10.8%) students had their sexual debut at 10 to 14 years, 9 (12.1%) had more than five sexual partners and 21 (23.4%) never used condom during sexual intercourse.Conclusion: The knowledge about HPV infection and uptake of HPV vaccine were very low in this study. Concerted effort should be made by health authorities to create awareness about HPV infection and its vaccine among university students. This will improve HPV vaccine uptake, prevent HPV infections and reduce the prevalence of cervical cancer.

scholarly journals Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study (Preprint)

2020 ◽  
Author(s):  
Anne M Teitelman ◽  
Emily F Gregory ◽  
Joshua Jayasinghe ◽  
Zara Wermers ◽  
Ja H Koo ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Technology Acceptance ◽  
Hpv Vaccine ◽  
Hpv Vaccination ◽  
Behavioral Model ◽  
The United States ◽  
Mobile App ◽  
Vaccine Uptake ◽  
Human Papillomavirus Vaccine ◽  
Vaccination Rates

BACKGROUND More than 90% of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine, yet vaccine use in the United States falls short of public health goals. OBJECTIVE The purpose of this study was to describe the development, acceptability, and intention to use the mobile app Vaccipack, which was designed to promote uptake and completion of the adolescent HPV vaccine series. METHODS Development of the mobile health (mHealth) content was based on the integrated behavioral model (IBM). The technology acceptance model (TAM) was used to guide the app usability evaluation. App design utilized an iterative process involving providers and potential users who were parents and adolescents. App features include a vaccine-tracking function, a discussion forum, and stories with embedded messages to promote intention to vaccinate. Parents and adolescents completed surveys before and after introducing the app in a pediatric primary care setting with low HPV vaccination rates. RESULTS Surveys were completed by 54 participants (20 adolescents aged 11 to 14 years and 34 parents). Notably, 75% (15/20) of adolescents and 88% (30/34) of parents intended to use the app in the next 2 weeks. Acceptability of the app was high among both groups: 88% (30/34) of parents and 75% (15/20) of adolescents indicated that Vaccipack was easy to use, and 82% (28/34) of parents and 85% (17/20) of adolescents perceived the app to be beneficial. Higher levels of app acceptability were found among parents with strong intentions to use the app (<i>P</i>=.09; 95% CI –2.15 to 0.15). CONCLUSIONS mHealth technology, such as Vaccipack, may be an acceptable and nimble platform for providing information to parents and adolescents and advancing the uptake of important vaccines.

scholarly journals Human Papillomavirus Infection and Vaccination: Knowledge, Attitude and Perception among Undergraduate Men and Women Healthcare University Students in Switzerland

Vaccines ◽  
2019 ◽  
Vol 7 (4) ◽  
pp. 130 ◽  
Author(s):  
Jeannot ◽  
Viviano ◽  
Follonier ◽  
Kaech ◽  
Oberhauser ◽  
...  
Keyword(s):  
Women Students ◽  
Human Papillomavirus ◽  
Undergraduate Students ◽  
Hpv Vaccine ◽  
Hpv Infection ◽  
Basic Knowledge ◽  
Transmitted Infection ◽  
Men And Women ◽  
Knowledge And Beliefs ◽  
Mode Of Transmission

Abstract: Background: Human Papillomavirus is a common sexually transmitted infection, representing the main cause of genital warts and cervical cancer. The objective of this study was to evaluate basic knowledge and beliefs regarding HPV infection and HPV vaccine among undergraduate healthcare men and women students, as well as their attitudes towards HPV vaccine. Methods: Undergraduate women and men (nursing and midwifery curses) attending three Schools of Health Sciences located in Switzerland. A total of 427 women and 223 men have completed the web questionnaire, which included questions on their socio-demographic background and about basic knowledge and attitudes toward the HPV infection and vaccination. Results: Women undergraduate students have a better knowledge of HPV infection than their men counterparts, although there was a significant gap in knowledge of the disease’s mode of transmission and prevention. Among women, 72.6% of respondents reported having received at least one dose of HPV vaccines versus 31.4% for men respondents. Conclusion: The results of this study revealed a poor understanding among undergraduate healthcare men and women students about the HPV infection, its mode of transmission and its prevention. Our findings highlight the need to improve education on HPV for undergraduate healthcare students in order to increase the awareness of the disease.

Sign in / Sign up

Export Citation Format

Share Document